Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @SpringBankPharm
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @SpringBankPharm
-
Prikvačeni tweet
Learn about inarigivir (SB 9200),
$SBPH's most advanced SMNH product candidate, & its novel method of action: http://bit.ly/2yOdYih#HBVHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Designed to resemble naturally occurring nucleotides and nucleic acids in the body, our SMNH compounds cause no observed non-specific immune response and target a broad range of disease, including viral diseases and cancers.
#oncology$SBPH: https://bit.ly/2QuXgN1 pic.twitter.com/xz0QaAaWmT
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Developed for the treatment of
#HBV, inarigivir is an orally-available selective immunomodulator that stimulates the innate immune response and inhibits viral replication. Watch this video to learn more$SBPH:https://bit.ly/2CVDtOJHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Citing our two clinical programs, multiple data readouts, high quality partners and a cash runway beyond 2021,
@InvestWatchBlog notes that Spring Bank could be undervalued. Read more.$SBPH: https://bit.ly/2KAKRTP FLS Disclaimer: https://bit.ly/36HTrsH pic.twitter.com/ZvQjWU2B4G
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Inarigivir selectively activates within cells infected with
#HBV, inhibiting viral replication and causing the induction of intracellular interferon signaling pathways for antiviral defense. Learn more about this mechanism here$SBPH: https://bit.ly/35fjFlG pic.twitter.com/CWpIidYXBb
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Among our pipeline of compounds, we plan to focus most on the inarigivir compound for
#HBV treatment and SB 11285 for#oncology applications. See our full pipeline here.$SBPH: https://bit.ly/2OnoHWq pic.twitter.com/Nx6bn7VmMi
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We design our proprietary SMNH compounds to bind specifically to their intended proteins, producing high therapeutic benefit over current therapies. We are committed to the highest standards of scientific excellence and integrity
$SBPH: https://bit.ly/2OuUXXQ pic.twitter.com/sIxS3N9VUk
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
STimulator of INterferon Genes, or STING, is a protein that can activate the body’s innate immune system. SB 11285 is an
#immunotherapy agent that activates the STING pathway currently being developed for the treatment of some cancers.$SBPH: https://bit.ly/2OoHTD7 pic.twitter.com/xXnvWxvBsx
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We released results from the first cohort of the clinical trial examining the co-administration of the low dose of inarigivir 50mg and the nucleoside analog, Vemlidy®.
$SBPH. Learn more about this trial here from@biospace: https://bit.ly/2OwewPc pic.twitter.com/FcpDg9HXBh
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Novel Small Molecule Drug Discovery Platform Harnesses Immune System to Defeat Cancers, Viral Infections & Inflammatory Diseases. Read the article from Dr. Kris Iyer in Drug Development & Delivery
@dddmag (FLS Disclaimer: https://bit.ly/2rudoEo ): https://bit.ly/36iimCT pic.twitter.com/fwaCVwewVN
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Designed to resemble naturally occurring nucleotides and nucleic acids in the body, our SMNH compounds are relatively easy to manufacture and include no observed non-specific immune response
$SBPH : https://bit.ly/32OqNVl pic.twitter.com/piBC3jMoLf
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Inarigivir, our most advanced product candidate, has the potential to provide a functional cure for
#HBV. Watch this video to learn more about inarigivir’s novel mechanism of action$SBPH:https://bit.ly/2WbaTBUHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are a clinical-stage
#biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using our proprietary small molecule nucleic acid hybrid platform. Want more investment-relevant info? Check here$SBPH: https://bit.ly/33V2wwW pic.twitter.com/PbgdO0xZpW
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Learn all about our development pipelines in our three main therapeutic areas:
#HBV,#oncology, and inflammatory diseases$SBPH: https://bit.ly/2onRqS4 pic.twitter.com/dNtQplSI4A
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
At Spring Bank, we are committed to the highest standards of scientific excellence and integrity for the benefit of patients and the medical community. Learn more about our mission
$SBPH: https://bit.ly/3672DY8 pic.twitter.com/uKTzzOFaMo
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our small molecule nucleic acid hybrid compounds act directly on target proteins, and have the potential to be used as part of combinatorial treatments, for example in
#HBV with other antivirals$SBPH: https://bit.ly/32OqNVl pic.twitter.com/whGckrx6JN
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Since inception, we have sought to apply our small molecule nucleic acid hybrid chemistry platform toward the discovery and development of novel drugs. The work has culminated in inarigivir, which is now being studied in Phase 2 clinical trials
$SBPH: https://bit.ly/341IbG5 pic.twitter.com/WSou9NjdUO
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Want to dive deep into the science and documentation behind our technology? Take a look at our publications
$SBPH: https://bit.ly/2PfWLpw pic.twitter.com/q7udMO3XaJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
STimulator of INterferon Genes, or STING, is a protein that has the power to activate the body’s innate immune system. SB 11285 is a potent immunotherapeutic agent that activates the STING pathway. Read more about it here.
#oncology$SBPH: https://bit.ly/32NmIkb pic.twitter.com/XOYORLL6n3
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are focusing the development of our two most advanced product candidates, inarigivir and SB 11285, on the treatment of
#HBV and various cancers respectively$SBPH: https://bit.ly/2onRqS4 pic.twitter.com/YciDdxZz9j
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Did you know that attaining a functional cure for chronic
#HBV will likely require modulation of the immune system? Our product candidate inarigivir is being developed with this in mind. Learn more about it$SBPH: https://bit.ly/2BJMqu8 pic.twitter.com/wsohUWv7E7
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.